PubMed

High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report.

Stiff PJ, Veum-Stone J, Lazarus HM, Ayash L, Edwards JR, Keating A, Klein JP, Oblon DJ, Shea TC, Thomé S, Horowitz MM.

Ann Intern Med. 2000 Oct 3;133(7):504-15.PMID: 11015163 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose chemotherapy with autologous transplantation for persistent/relapsed ovarian cancer: a multivariate analysis of survival for 100 consecutively treated patients.

Stiff PJ, Bayer R, Kerger C, Potkul RK, Malhotra D, Peace DJ, Smith D, Fisher SG.

J Clin Oncol. 1997 Apr;15(4):1309-17.PMID: 9193322 [PubMed - indexed for MEDLINE]Related articles

High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors.

McGuire WP.

Curr Probl Cancer. 1998 May-Jun;22(3):135-77. Review.PMID: 9659570 [PubMed - indexed for MEDLINE]Related articles

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.

Elias AD, Ibrahim J, Richardson P, Avigan D, Joyce R, Reich E, McCauley M, Wheeler C, Frei E 3rd.

Biol Blood Marrow Transplant. 2002;8(4):198-205.PMID: 12017145 [PubMed - indexed for MEDLINE]Related articles

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM; Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee.

J Clin Oncol. 2001 Jan 15;19(2):406-13.PMID: 11208832 [PubMed - indexed for MEDLINE]Related articles

Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer.

Rowlings PA, Williams SF, Antman KH, Fields KK, Fay JW, Reed E, Pelz CJ, Klein JP, Sobocinski KA, Kennedy MJ, Freytes CO, McCarthy PL Jr, Herzig RH, Stadtmauer EA, Lazarus HM, Pecora AL, Bitran JD, Wolff SN, Gale RP, Armitage JO, Vaughan WP, Spitzer G, Horowitz MM.

JAMA. 1999 Oct 13;282(14):1335-43.PMID: 10527180 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.PMID: 12042984 [PubMed - indexed for MEDLINE]Related articles

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).

Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM.

Bone Marrow Transplant. 2001 Feb;27(4):387-96.PMID: 11313668 [PubMed - indexed for MEDLINE]Related articlesFree article

Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry.

Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM.

J Clin Oncol. 1999 Feb;17(2):534-45.PMID: 10080597 [PubMed - indexed for MEDLINE]Related articles

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study.

Stiff PJ, Shpall EJ, Liu PY, Wilczynski SP, Callander NS, Scudder SA, Jazieh AR, Samlowski W, McCoy J, Alberts DS; Southwest Oncology Group Study.

Gynecol Oncol. 2004 Jul;94(1):98-106.PMID: 15262126 [PubMed - indexed for MEDLINE]Related articles

Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.

Schneeweiss A, Hensel M, Sinn P, Khbeis T, Haas R, Bastert G, Ho AD.

Ann Oncol. 2002 May;13(5):679-88.PMID: 12075735 [PubMed - indexed for MEDLINE]Related articlesFree article

High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer.

Farquhar C, Marjoribanks J, Basser R, Hetrick S, Lethaby A.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003142. Review.PMID: 16034887 [PubMed - indexed for MEDLINE]Related articles

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.PMID: 11535983 [PubMed - indexed for MEDLINE]Related articles

High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT).

Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T; EBMT Solid Tumor Working Party.

Bone Marrow Transplant. 2005 Jul;36(1):25-31.PMID: 15908977 [PubMed - indexed for MEDLINE]Related articles

Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.

Schetelig J, Fetscher S, Reichle A, Berdel WE, Beguin Y, Brunet S, Caballero D, Majolino I, Hagberg H, Johnsen HE, Kimby E, Montserrat E, Stewart D, Copplestone A, Rösler W, Pavel J, Kingreen D, Siegert W.

Haematologica. 2003 Nov;88(11):1272-8.PMID: 14607756 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome.

Elias AD, Skarin AT, Richardson P, Ibrahim J, McCauley M, Frei E 3rd.

Biol Blood Marrow Transplant. 2002;8(6):326-33.PMID: 12108918 [PubMed - indexed for MEDLINE]Related articles

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients.

Holloway RW, Mehta RS, Finkler NJ, Li KT, McLaren CE, Parker RJ, Fruehauf JP.

Gynecol Oncol. 2002 Oct;87(1):8-16.PMID: 12468336 [PubMed - indexed for MEDLINE]Related articles

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.

Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E 3rd, Ayash L.

Bone Marrow Transplant. 2001 Feb;27(3):269-78.PMID: 11277174 [PubMed - indexed for MEDLINE]Related articlesFree article

Autologous stem cell transplantation for small cell lung cancer.

Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM.

Biol Blood Marrow Transplant. 2002;8(5):273-80.PMID: 12064365 [PubMed - indexed for MEDLINE]Related articles

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.

Shinozuka T, Miyamoto T, Muramatsu T, Hirasawa T, Murakami M, Makino T, Tanaka Y.

Cancer. 1999 Apr 1;85(7):1555-64.PMID: 10193946 [PubMed - indexed for MEDLINE]Related articlesFree article